Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2021.01.15.426463: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources Polyclonal rabbit anti-S1 antibody (Sinobiological, Cat: 40592-T62) and anti-S2 antibody (Abcam, Cat: ab272504) were used as primary antibodies. anti-S1suggested: Noneanti-S2suggested: NoneCells were washed 3 × with PBS-BSA-0.5% then incubated for 1h at RT with secondary antibodies conjugated with Alexafluor488 diluted at 1:1000 in PBS-BSA 0.5% (for ChAdOx1 nCov-19 serum staining Goat Anti mouse AlexaFluor 488 (Life Tech A11029) Anti mousesuggested: (Thermo Fisher Scientific Cat# A-11029, RRID:AB_2534088)Isolation of human monoclonal antibodies from peripheral B cells by spike-specific single B cells … SciScore for 10.1101/2021.01.15.426463: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources Polyclonal rabbit anti-S1 antibody (Sinobiological, Cat: 40592-T62) and anti-S2 antibody (Abcam, Cat: ab272504) were used as primary antibodies. anti-S1suggested: Noneanti-S2suggested: NoneCells were washed 3 × with PBS-BSA-0.5% then incubated for 1h at RT with secondary antibodies conjugated with Alexafluor488 diluted at 1:1000 in PBS-BSA 0.5% (for ChAdOx1 nCov-19 serum staining Goat Anti mouse AlexaFluor 488 (Life Tech A11029) Anti mousesuggested: (Thermo Fisher Scientific Cat# A-11029, RRID:AB_2534088)Isolation of human monoclonal antibodies from peripheral B cells by spike-specific single B cells sorting: To isolate Spike-specific B cells, PBMCs were labelled with recombinant trimeric spike-twin-Strep and stained with antibody cocktail consisting of CD3-FITC, CD14-FITC, CD56-FITC, CD16-FITC, IgM-FITC, IgA-FITC, IgD-FITC, IgG-BV786, CD19-BUV395 and Strep-MAB-DY549 (iba) to probe the Strep tag of spike. IgG-BV786suggested: NoneCD19-BUV395suggested: NoneExperimental Models: Cell Lines Sentences Resources Western blot analysis: Protein pellets from the HEK293F cell lysates were loaded onto an SDS-PAGE gel, then transferred to a PVDF membrane. HEK293Fsuggested: RRID:CVCL_6642)FACS analysis for cell surface spike expression: Hela S3 cells at 4 ×105 cell/ml were infected with 10 MOI ChAdOx1 nCoV-19 and incubated at 37°C for 40-48h. Hela S3suggested: NonePlasmids encoding heavy and light chains were then co-transfected into the 293T cell line by the polyethylenimine method (408727; Sigma), and antibody were harvested for further study. 293Tsuggested: None1.6×105 of U2OS or HeLa cells resuspended in 2 ml of DMEM 10% FBS, Pen/Strep were seeded on top of the grids in, in 6 well plate wells. U2OSsuggested: NoneHeLasuggested: NoneSoftware and Algorithms Sentences Resources Data were analysed using FlowJo v9 (TreeStar). FlowJosuggested: (FlowJo, RRID:SCR_008520)Tilt series were acquired using SerialEM (44) at a pixel size of 2.13 Å. SerialEMsuggested: (SerialEM, RRID:SCR_017293)Movies were subsequently gain normalised during motion correction and Fourier cropped back to physical pixel size with MotionCor2 (46). MotionCor2suggested: (MotionCor2, RRID:SCR_016499)A representative glycoform presented at each site was modelled on to the N-linked carbohydrate attachment sites in Coot (50). Cootsuggested: (Coot, RRID:SCR_014222)Mass spectrometry raw files have been deposited in the MassIVE proteomics database (DOI: XXX). MassIVEsuggested: NoneResults from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
